BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 15686493)

  • 1. Identification of autotaxin as a neurite retraction-inducing factor of PC12 cells in cerebrospinal fluid and its possible sources.
    Sato K; Malchinkhuu E; Muraki T; Ishikawa K; Hayashi K; Tosaka M; Mochiduki A; Inoue K; Tomura H; Mogi C; Nochi H; Tamoto K; Okajima F
    J Neurochem; 2005 Feb; 92(4):904-14. PubMed ID: 15686493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lysophosphatidic acid and autotaxin stimulate cell motility of neoplastic and non-neoplastic cells through LPA1.
    Hama K; Aoki J; Fukaya M; Kishi Y; Sakai T; Suzuki R; Ohta H; Yamori T; Watanabe M; Chun J; Arai H
    J Biol Chem; 2004 Apr; 279(17):17634-9. PubMed ID: 14744855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Production of lysophosphatidic acid in blister fluid: involvement of a lysophospholipase D activity.
    Mazereeuw-Hautier J; Gres S; Fanguin M; Cariven C; Fauvel J; Perret B; Chap H; Salles JP; Saulnier-Blache JS
    J Invest Dermatol; 2005 Sep; 125(3):421-7. PubMed ID: 16117781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of lysophosphatidic acid in the regulation of uterine leiomyoma cell proliferation by phospholipase D and autotaxin.
    Billon-Denis E; Tanfin Z; Robin P
    J Lipid Res; 2008 Feb; 49(2):295-307. PubMed ID: 18024704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simultaneous stimulation of spinal NK1 and NMDA receptors produces LPC which undergoes ATX-mediated conversion to LPA, an initiator of neuropathic pain.
    Inoue M; Ma L; Aoki J; Ueda H
    J Neurochem; 2008 Dec; 107(6):1556-65. PubMed ID: 19014389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autotaxin has lysophospholipase D activity leading to tumor cell growth and motility by lysophosphatidic acid production.
    Umezu-Goto M; Kishi Y; Taira A; Hama K; Dohmae N; Takio K; Yamori T; Mills GB; Inoue K; Aoki J; Arai H
    J Cell Biol; 2002 Jul; 158(2):227-33. PubMed ID: 12119361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lysophosphatidylcholine induces neuropathic pain through an action of autotaxin to generate lysophosphatidic acid.
    Inoue M; Xie W; Matsushita Y; Chun J; Aoki J; Ueda H
    Neuroscience; 2008 Mar; 152(2):296-8. PubMed ID: 18280050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autotaxin and lysophosphatidic acid stimulate intestinal cell motility by redistribution of the actin modifying protein villin to the developing lamellipodia.
    Khurana S; Tomar A; George SP; Wang Y; Siddiqui MR; Guo H; Tigyi G; Mathew S
    Exp Cell Res; 2008 Feb; 314(3):530-42. PubMed ID: 18054784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for de novo synthesis of lysophosphatidic acid in the spinal cord through phospholipase A2 and autotaxin in nerve injury-induced neuropathic pain.
    Ma L; Uchida H; Nagai J; Inoue M; Aoki J; Ueda H
    J Pharmacol Exp Ther; 2010 May; 333(2):540-6. PubMed ID: 20123931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation and biological activities of the autotaxin-LPA axis.
    van Meeteren LA; Moolenaar WH
    Prog Lipid Res; 2007 Mar; 46(2):145-60. PubMed ID: 17459484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms of lysophosphatidic acid production.
    Aoki J
    Semin Cell Dev Biol; 2004 Oct; 15(5):477-89. PubMed ID: 15271293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lysophosphatidic acids, cyclic phosphatidic acids and autotaxin as promising targets in therapies of cancer and other diseases.
    Gendaszewska-Darmach E
    Acta Biochim Pol; 2008; 55(2):227-40. PubMed ID: 18560605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lysophospholipids in the limelight: autotaxin takes center stage.
    Moolenaar WH
    J Cell Biol; 2002 Jul; 158(2):197-9. PubMed ID: 12135981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blocking lysophosphatidic acid receptor 1 signaling inhibits diabetic nephropathy in db/db mice.
    Li HY; Oh YS; Choi JW; Jung JY; Jun HS
    Kidney Int; 2017 Jun; 91(6):1362-1373. PubMed ID: 28111010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deficiency of autotaxin/lysophospholipase D results in head cavity formation in mouse embryos through the LPA receptor-Rho-ROCK pathway.
    Koike S; Keino-Masu K; Masu M
    Biochem Biophys Res Commun; 2010 Sep; 400(1):66-71. PubMed ID: 20692235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lysophosphatidic acid induces neurite branch formation through LPA3.
    Furuta D; Yamane M; Tsujiuchi T; Moriyama R; Fukushima N
    Mol Cell Neurosci; 2012 May; 50(1):21-34. PubMed ID: 22465231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lysophosphatidic acid-3 receptor-mediated feed-forward production of lysophosphatidic acid: an initiator of nerve injury-induced neuropathic pain.
    Ma L; Uchida H; Nagai J; Inoue M; Chun J; Aoki J; Ueda H
    Mol Pain; 2009 Nov; 5():64. PubMed ID: 19912636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel autotaxin inhibitor reduces lysophosphatidic acid levels in plasma and the site of inflammation.
    Gierse J; Thorarensen A; Beltey K; Bradshaw-Pierce E; Cortes-Burgos L; Hall T; Johnston A; Murphy M; Nemirovskiy O; Ogawa S; Pegg L; Pelc M; Prinsen M; Schnute M; Wendling J; Wene S; Weinberg R; Wittwer A; Zweifel B; Masferrer J
    J Pharmacol Exp Ther; 2010 Jul; 334(1):310-7. PubMed ID: 20392816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrin alpha6beta4 promotes expression of autotaxin/ENPP2 autocrine motility factor in breast carcinoma cells.
    Chen M; O'Connor KL
    Oncogene; 2005 Jul; 24(32):5125-30. PubMed ID: 15897878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of human plasma lysophospholipase D, a lysophosphatidic acid-producing enzyme, as autotaxin, a multifunctional phosphodiesterase.
    Tokumura A; Majima E; Kariya Y; Tominaga K; Kogure K; Yasuda K; Fukuzawa K
    J Biol Chem; 2002 Oct; 277(42):39436-42. PubMed ID: 12176993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.